Call us Toll-Free
800-476-6070

Weitz & Luxenberg Facebook Weitz & Luxenberg Google Weitz & Luxenberg Twitter Weitz & Luxenberg LinkedIn
English En Français

FREE LEGAL REVIEW

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
Were you diagnosed with lung cancer? Yes
Were you diagnosed with Mesothelioma? yes
What is your date of diagnosis?
Additional Comments
Best time to call?

Weitz & Luxenberg Recognizes New Advance in Mesothelioma Treatment--Vinflunine successfully tested

December 17, 2007, New York, NY—Research hospitals in Europe have successfully tested a new anticancer drug, “Vinflunine” (pronounced VIN-floo-neen). The October 20th issue of Journal of Clinical Oncology featured the news that Vinflunine has been shown to improve response and survival rates in patients diagnosed with malignant pleural mesothelioma, according to Reuters.

Mesothelioma is a rare, deadly form of cancer that affects the inside lining of the chest cavity and is directly associated with asbestos exposure.

Of the promise Vinflunine could hold, Ben Darche, an attorney with the Asbestos Litigation Unit at Weitz & Luxenberg, P.C., said, “We commend the medical advances being made by Dr. Denis C. Talbot and his colleagues. Through my work I have witnessed the emotional and financial suffering mesothelioma places on patients and their families. Any medical advance is no small miracle.”

Weitz & Luxenberg, P.C., commends this recent medical advance and the doctors that achieved it. During many years of representing clients suffering from mesothelioma, Weitz & Luxenberg has seen first-hand the pain and suffering the disease has on victims and their loved ones. Most mesothelioma patients, for example, die within one year of being diagnosed. There is no known cure for mesothelioma.

Vinflunine was recently tested in Phase II clinical trials at hospital research centers in England and France. Dr. Talbot, from the Churchill Hospital in Oxford, and medical colleagues at seven European hospital centers, assessed the response rates of 67 patients who had not received prior chemotherapy or radiotherapy to determine the effectiveness of first-line Vinflunine treatment.

Doctors concluded that Vinflunine, when administered approximately every 21 days in high doses, improved patients’ response rates by 13.8 percent, and demonstrated such positive results that the drug therapy warrants further evaluation. In 2004, the Food and Drug Administration approved the first drug for this condition, “Alimta,” which, when used in combination with cisplatin, has helped patients extend their lives by several months, according to the FDA.

About 2,000 cases of mesothelioma are diagnosed in the United States every year, based on statistics from the National Cancer Institute. Current treatments are limited and usually include some form of surgery, combined with chemotherapy or radiation. The disease, which is often linked to industrial workplace exposure to asbestos, is usually contracted through employers’ disregard for health safety.

Weitz & Luxenberg specializes in the prosecution of asbestos-related work cases and has won many multi-million-dollar verdicts and settlements for victims’ families to help them offset medical expenses and compensate for suffering.Weitz & Luxenberg’s successes date back to 1991 with a historic consolidated trial involving men who worked at the Brooklyn Navy Yard during and after World War II. Weitz & Luxenberg represented 36 clients in that case, securing a verdict of $75 million.

Please contact us if we can help as you move forward with legal options. For a free legal review, complete the brief form below and we will be in touch shortly.

Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
Diagnosis Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos
Mesothelioma couple Real Stories


Mesothelioma
Mesothelioma Resource Center
Mesothelioma
Information about Diagnosis
Latest News
IN THIS SECTION
Weakened Asbestos Bill
Asbestos Lawsuits: Verdict
Fraudulent Asbestos Training
Asbestos: Sheffield
Ambre Brandis Joins Firm
$37 Mil Asbestos Lung Cancer
Vinflunine
Asbestos and Smokers
Asbestos & Lung Cancer
Mesothelioma Ad
Ban Asbestos in America Act
Asbestos Found in Toys
NIOSH Roadmap
Client Letter
Illegal Asbestos Abatement
Senate Ban, 10.07
National Asbestos Awareness Week
Asbestos Diseases Awareness
Frank Ortiz
Asbestosis Deaths in New York
Asbestos Disease Awareness
Asbestos Abatement
Asbestos and Boilermakers
Navy Veterans
2010 Asbestos Awareness Day
Asbestosis Treatments
Symptoms of Asbestosis
Treatment of Mesothelioma

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

Mesothelioma Lawyer

Asbestos Lawyer

Mesothelioma Treatments

Mesothelioma Treatment

Mesothelioma Diagnosis

Mesothelioma Treatment

see also:

NIOSH Roadmap Weitz & Luxenberg Responds: The NIOSH Asbestos Roadmap—Too Late
NIOSH Addresses Scientific Questions about Asbestos and Job Exposure

Weakened Asbestos Bill Asbestos Bill Weak | Weitz & Luxenberg
Advocates Disappointed by Weakened Ban Asbestos Bill--Get Lawsuit Info

Press Releases Press releases about Weitz & Luxenberg's asbestos practice
Read Weitz & Luxenberg's press releases on asbestos news
View Stats